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345 and 346.352 The Journal of Thoracic and CardioWhen evaluating organs for lung-transplant recipients, manyissues need to be considered. Donor factors play a key rolein the evaluation of organs for transplantation: age, medicalhistory, smoking history, adequate gas exchange, normalbronchoscopy, serologies, ABO compatibilities, and sizematching. Donor and recipient gender are neither directly
considered nor matched. Should they be? Do the inherent differences between men
and women matter in lung transplantation?
There are several reasons to expect a difference when transplanting across organ
and recipient gender. Gender-associated differences could play a role in terms of
graft survival, organ size, metabolic demands, circulating hormones, and receptors.
There are gender-associated immunologic phenomena, such as the female’s ability
to tolerate certain alloantigens during pregnancy. Does this affect graft survival?
Does the fact that women are more susceptible to autoimmune disease play a role
in tolerance? For lung transplantation, the data are relatively sparse. However,
differences observed in other transplanted organs might give us a clue.
With respect to kidney transplantation, Inoue and colleagues1 examined 205
kidney transplantations performed over a 13-year period and found that long-term
graft survival was better in female than in male recipients. Cyclosporine (INN:
ciclosporin) troughs and steroid dosing tended to be lower among female recipients.
When graft survival was analyzed among the 4 possible matched scenarios on the
basis of gender, female-to-female transplantation had the best graft survival,
whereas male-to-male transplantation had the worst. This issue has been addressed
in an animal model of renal allografts in which a protective effect of estradiol was
observed on chronic rejections.2,3 However, these findings have not been universal.
Multiple studies confirm a worse prognosis for female kidneys transplanted into
male recipients when compared with male kidneys transplanted into female recip-
ients.4,5 Two hypotheses have been proposed to explain this: the concept of nephron
underdosing (ie, the kidney mass is proportionally less in male patients receiving a
female kidney) and the hypothesis that there are different immunologic mechanisms
playing a role in graft survival. In attempting to evaluate the effect of gender on graft
survival and the underlying mechanism, a large study using the database of the
Collaborative Transplant Study analyzed graft survival according to donor and
recipient gender for renal (n  124,911), cardiac (n  25,432), and hepatic (n 
16,410) organs. This study attempted to discern whether the gender effect observed
in renal transplantation was related to inherent immunologic mechanisms or
nephron underdosing. If the effect was observed in kidneys alone, this would point
toward nephron underdosing, whereas an effect across all organs would suggest an
immunologic mechanism. Several cofactors were considered, including calendar
year, geographic location, race, donor and recipient age, HLA mismatch, and cold
ischemic time. Survival of cadaveric renal transplants was consistently lower when
the donor was female. From this study, there was a donor gender-associated risk
ratio of 1.15 in female recipients and 1.22 in male recipients. The gender effect
observed was more pronounced for younger (45 years) compared with older
donors (45 years). This effect was observed even in HLA-identical siblings.
Because the observed effect was age associated, the role of hormonal milieu on graft
survival is likely to be important. When the authors looked at cardiac transplanta-
tions, again there was a gender-associated risk ratio of 1.13 for the graft of female
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Ldonor organs into male recipients. There was no difference
in graft survival from male donor organs into either female
or male recipients. These observations are similar to those
reported in other smaller studies.6,7 A similar effect has
been observed in hepatic transplantation. Kahn and cowork-
ers8 reported a 3.7-fold higher risk of graft failure in livers
from female donors transplanted into male recipients. This
has been confirmed in several other series.9,10
Data from animal studies suggest immunologic mecha-
nisms might play a role. Female kidneys display more HLA
antigens and are more antigenic than their male counter-
parts.11 However, HLA matching does not obliterate the
observed gender effects, and therefore other mechanisms
could play a role. There might be an effect at the donor-
recipient interface, perhaps at the level of the vascular
endothelium. Endothelial cells have different responses to
androgens and estrogens.12 In animal studies of heart allo-
graft transplantation during cyclosporine use, 4 gender com-
binations were used to examine the effect of donor and
recipient gender on graft survival.13 In this study graft
survival was significantly worse in female recipients, and
this effect could be attenuated with tamoxifen.
For lung transplantation, there are relatively fewer pro-
cedures performed, and therefore the data are scarce. As of
yet, there are no published animal studies that evaluate the
effect of gender on pulmonary graft function or survival,
although some human data attempt to address this issue.
Christie and associates14 analyzed organ and recipient gen-
der on the incidence of primary graft failure. Female donor
gender was associated with the development of graft failure,
with an unadjusted risk ratio of 3.99 (95% confidence in-
terval [CI], 1.74-9.11; P  .001). This remained significant
when adjusted for all other risk factors. Although recipient
gender initially appears to have an effect as well, statistical
significance was lost when adjusted for donor gender.
In the 19th official registry report of the International
Society for Heart and Lung Transplantation,15 donor-recip-
ient gender mismatch was a risk factor for 1-year mortality,
with an odds ratio of 1.19 (95% CI, 1.03-1.37; P .02), and
female recipient gender was a risk factor for 5-year mortal-
ity, with an odds ratio of 0.74 (95% CI, 0.61-0.90; P 
.002) in transplantations performed between April 1994 and
December 1996. However, in the more recent 20th official
report,16 donor or recipient gender was not identified as a
significant risk factor for either 1- or 5-year mortality.
For lung transplantation, the issue of gender and its
implications on graft function and long-term survival have
not been clearly established. Certainly, the effects of gender
and hormones might more easily be isolated and analyzed in
The Journal of Thoracian animal model, but the applicability to human subjects
will not be known until additional clinical data become
available. As we continue to improve on other factors that
affect outcome in lung transplantation, gender mismatch
needs to be more carefully investigated to determine
whether it is truly a risk factor for long-term graft survival.
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